Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab (Br J Surg 2012; 99: 1575-1582).

The British journal of surgery - 1 Nov 2012

Mentha G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to KRAS gene
Share to Genes, ras
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 23027076
DOI: 10.1002/bjs.8910

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab (Br J Surg 2012; 99: 1575-1582).PMID 23027076Read ↗

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.Semantic proximity Read ↗

Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.Semantic proximity Read ↗

Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Semantic proximity Read ↗

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.Semantic proximity Read ↗

The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases.Semantic proximity Read ↗

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Semantic proximity Read ↗

Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.Semantic proximity Read ↗

Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.Semantic proximity Read ↗

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Mutation Status of RAS, TP53 , and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver MetastasesSemantic proximity Read ↗

Surgery: KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases.Semantic proximity Read ↗

Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.